Table 1 Associations of ADAMTS9-AS1 expression with clinicopathological factors
Characteristics | Number of patients | ADAMTS9-AS1 | χ2 | P value | |
|---|---|---|---|---|---|
High expression (%) | Low expression (%) | ||||
Gender | 3 | 0.083 | |||
Male | 20 | 7(28.00) | 13(52.00) | ||
Female | 30 | 18(72.00) | 12(48.00) | ||
Age | 2.381 | 0.123 | |||
≤ 65 | 35 | 20(80.00) | 15(60.00) | ||
> 65 | 15 | 5(20.00) | 10(40.00) | ||
TNM stage | 10.272 | 0.001 | |||
I + II | 31 | 10(40.00) | 21(84.00) | ||
III + IV | 19 | 15(60.00) | 4(16.00) | ||
Grade | 6.876 | 0.009 | |||
Grade 1 + 2 | 31 | 11(44.00) | 20(80.00) | ||
Grade 3 + 4 | 19 | 14(56.00) | 5(20.00) | ||
Lymph node metastasis | 7.714 | 0.005 | |||
No | 35 | 13(52.00) | 22(88.00) | ||
Yes | 15 | 12(48.00) | 3(12.00) | ||
Distant metastasis | 6.818 | 0.009 | |||
M0 | 44 | 19(76.00) | 25(100.00) | ||
M1 | 6 | 6(24.00) | 0(0.00) | ||